Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding Vigil Neuroscience, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 54 | 58 | +4 |
| Shares | 26.5M | 26.1M | −385.3K (−1.5%) |
| Value | $90.5M | $104.5M | +$14.0M (+15.4%) |
New holders (20)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 1,485,000 | $5.94M | 0.02% |
| StemPoint Capital LP | 744,412 | $2.98M | 0.88% |
| Woodline Partners LP | 206,614 | $826.5K | 0.01% |
| Jane Street Group, LLC | 62,354 | $249.4K | 0.00% |
| Susquehanna International Group, LLP | 48,051 | $192.2K | 0.00% |
| Alpine Global Management, LLC | 44,893 | $179.6K | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 38,364 | $153.5K | 0.01% |
| Centiva Capital, LP | 32,800 | $131.2K | 0.01% |
| Qube Research & Technologies Ltd | 30,429 | $121.7K | 0.00% |
| Walleye Capital LLC | 27,575 | $110.3K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 21,854 | $87.4K | 0.02% |
| Paloma Partners Management Co | 16,609 | $66.4K | 0.01% |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $32.5K | 0.00% |
| Acadian Asset Management LLC | 6,598 | $26.0K | 0.00% |
| Point72 (DIFC) Ltd | 5,506 | $22.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 4,100 | $16.4K | 0.00% |
| Cubist Systematic Strategies, LLC | 3,653 | $14.6K | 0.00% |
| Russell Investments Group, Ltd. | 2,029 | $8.12K | 0.00% |
| Macquarie Group Ltd | 831 | $3.32K | 0.00% |
| Nisa Investment Advisors, LLC | 75 | $300 | 0.00% |
Sold out (16)
Institutions that held Vigil Neuroscience, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 980,311 | $3.34M |
| DAFNA Capital Management LLC | 71,815 | $244.9K |
| Bank of Montreal | 33,368 | $234.9K |
| Bank of New York Mellon Corp | 45,750 | $156.0K |
| Charles Schwab Investment Management Inc | 41,968 | $143.1K |
| Nuveen Asset Management, LLC | 26,840 | $91.5K |
| Two Sigma Advisers, LP | 24,100 | $82.2K |
| Connor, Clark & Lunn Investment Management Ltd. | 19,178 | $65.4K |
| American International Group, Inc. | 7,919 | $27.0K |
| STRS Ohio | 7,700 | $26.0K |
| Wells Fargo & Company | 5,655 | $19.3K |
| Legal & General Group Plc | 1,554 | $5.27K |
| Ameritas Investment Partners, Inc. | 1,327 | $4.53K |
| Amalgamated Bank | 542 | $2.00K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $6 |
| Capital Advisors, Ltd. LLC | 4 | $0 |